Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of AERAS-402 [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating the safety and immunogenicity of AERAS-402 for tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• AERAS-402

Snippet

Sponsor: Aeras | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED